Second person dies in anti-obesity drug trial
8th December 2015
A second patient has died in a late-stage trial of the anti-obesity drug beloranib, according to a report in PharmaTimes.
Log In
Welcome to AusDoc.Plus, the new home of Australian Doctor, Medical Observer, 6minutes and How to Treat. You can use your existing login credentials for any of these sites to gain entry.
Not a member?
Join AusDoc.PLUS